Revvity, Inc. (RVTY)
123.00
-1.75
(-1.40%)
USD |
NYSE |
Aug 24, 16:00
122.92
-0.08
(-0.07%)
Pre-Market: 20:00
Revvity EPS Diluted (Quarterly) : 0.4642 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4642 |
| March 31, 2026 | 0.364 |
| December 31, 2025 | 0.8708 |
| September 30, 2025 | 0.4066 |
| June 30, 2025 | 0.4683 |
| March 31, 2025 | 0.3446 |
| December 31, 2024 | 0.78 |
| September 30, 2024 | 0.7638 |
| June 30, 2024 | 0.6407 |
| March 31, 2024 | 0.2244 |
| December 31, 2023 | 0.8322 |
| September 30, 2023 | 0.0769 |
| June 30, 2023 | 0.2836 |
| March 31, 2023 | 4.503 |
| December 31, 2022 | 1.088 |
| September 30, 2022 | 0.5493 |
| June 30, 2022 | 1.417 |
| March 31, 2022 | 1.397 |
| December 31, 2021 | 1.501 |
| September 30, 2021 | 0.9357 |
| June 30, 2021 | 2.188 |
| March 31, 2021 | 3.372 |
| December 31, 2020 | 3.380 |
| September 30, 2020 | 1.574 |
| June 30, 2020 | 1.226 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.302 |
| December 31, 2019 | 0.5778 |
| September 30, 2019 | 0.5249 |
| June 30, 2019 | 0.6195 |
| March 31, 2019 | 0.3182 |
| December 31, 2018 | 0.6388 |
| September 30, 2018 | 0.6878 |
| June 30, 2018 | 0.5798 |
| March 31, 2018 | 0.2338 |
| December 31, 2017 | -0.7519 |
| September 30, 2017 | 0.8711 |
| June 30, 2017 | 0.2139 |
| March 31, 2017 | 0.3503 |
| December 31, 2016 | 0.5888 |
| September 30, 2016 | 0.5223 |
| June 30, 2016 | 0.5814 |
| March 31, 2016 | 0.4269 |
| December 31, 2015 | 0.6064 |
| September 30, 2015 | 0.4837 |
| June 30, 2015 | 0.4303 |
| March 31, 2015 | 0.3557 |
| December 31, 2014 | 0.277 |
| September 30, 2014 | 0.3717 |
| June 30, 2014 | 0.4457 |
| March 31, 2014 | 0.3016 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.198 |
| Danaher Corp. | 1.230 |
| Thermo Fisher Scientific, Inc. | 4.679 |
| Waters Corp. | -1.385 |
| Bio-Rad Laboratories, Inc. | 13.85 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 53.48M |
| Revenue (Quarterly) | 729.69M |
| Total Expenses (Quarterly) | 676.21M |
| Enterprise Value | 16.04B |
| Gross Profit Margin (Quarterly) | 50.26% |
| Profit Margin (Quarterly) | 7.33% |
| Earnings Yield | 1.71% |
| Operating Earnings Yield | 3.24% |
| Normalized Earnings Yield | 2.283 |